Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Receptor-mediated recognition of Cryptococcus neoformans.

Levitz SM.

Nihon Ishinkin Gakkai Zasshi. 2002;43(3):133-6. Review.

2.
4.
7.

CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression.

Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, Vogel SN.

J Immunol. 2001 Jan 1;166(1):574-81.

9.

Binding of Cryptococcus neoformans to heterologously expressed human complement receptors.

Levitz SM, Tabuni A, Kozel TR, MacGill RS, Ingalls RR, Golenbock DT.

Infect Immun. 1997 Mar;65(3):931-5.

13.

Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo.

Yauch LE, Mansour MK, Levitz SM.

Infect Immun. 2005 Dec;73(12):8429-32.

15.
16.

Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.

Monari C, Retini C, Casadevall A, Netski D, Bistoni F, Kozel TR, Vecchiarelli A.

Eur J Immunol. 2003 Apr;33(4):1041-51.

17.

Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.

Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, Freeman MW, Mayadas T, Nizet V, Akira S, Kasper DL, Golenbock DT.

J Immunol. 2002 Oct 1;169(7):3970-7.

18.

Antifungal activity of a human antiglucuronoxylomannan antibody.

Zhong Z, Pirofski LA.

Clin Diagn Lab Immunol. 1998 Jan;5(1):58-64.

19.
20.

Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader.

Walenkamp AM, Scharringa J, Schramel FM, Coenjaerts FE, Hoepelman IM.

J Microbiol Methods. 2000 Mar;40(1):39-45.

PMID:
10739341
Items per page

Supplemental Content

Write to the Help Desk